Consideration of Costs and Open-label Studies of Erenumab.

Charles, James A

Consideration of Costs and Open-label Studies of Erenumab. [electronic resource] - JAMA neurology 02 2019 - 236 p. digital

Publication Type: Journal Article; Comment

2168-6157

10.1001/jamaneurol.2018.4150 doi


Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Calcitonin Gene-Related Peptide Receptor Antagonists
Humans
Migraine Disorders